Clinical Trial Update: Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients [Phase 4]

View source ↗

Summary

This entry notes a Phase 4 study investigating how dopamine affects loss aversion behavior in Parkinsonian patients; the current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN